AVADEL PHARMACEUTICALS PLC - SPONSORED ADR (AVDLXXXX)

Historical Portfolio Holders from Q4 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q1 2024
67.7 M
Holdings value Q1 2024
$1.14 B
Value change Q1 2024
+$220 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
116
Number of buys Q1 2024
71
Number of sells Q1 2024
-52
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.001%
CUSIP
05337M104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 67.7 M $1.14 B +$220 M $16.89 119
2023 Q4 55.1 M $778 M +$14.7 M $14.12 109
2023 Q3 53.8 M $555 M -$2.77 M $10.30 96
2023 Q2 51.5 M $848 M +$73.3 M $16.48 96
2023 Q1 48.2 M $442 M +$138 M $9.16 88
2022 Q4 29.5 M $212 M +$16.2 M $7.16 82
2022 Q3 27.6 M $139 M -$10.6 M $5.01 73
2022 Q2 30 M $73.2 M -$28.5 M $2.44 76
2022 Q1 35.8 M $245 M +$7 M $6.83 77
2021 Q4 34.9 M $282 M +$3.98 M $8.08 77
2021 Q3 29.5 M $289 M -$2.63 M $9.80 83
2021 Q2 30.1 M $202 M -$1.45 M $6.73 80
2021 Q1 30.1 M $272 M +$1.57 M $9.04 76
2020 Q4 30.1 M $201 M +$3.57 M $6.68 77
2020 Q3 29.6 M $149 M -$40.7 M $5.04 77
2020 Q2 34.4 M $278 M +$72.7 M $8.08 76
2020 Q1 25.3 M $200 M +$56.7 M $7.94 57
2019 Q4 18.2 M $138 M +$2.57 M $7.55 42
2019 Q3 19.4 M $80.6 M +$347 K $4.16 39
2019 Q2 19.3 M $55.8 M -$531 K $2.89 39
2019 Q1 19.6 M $28.2 M -$906 K $1.44 36
2018 Q4 19.7 M $50.9 M -$1.39 M $2.58 46
2018 Q3 20.1 M $88.4 M -$2.84 M $4.39 60
2018 Q2 20.6 M $126 M -$36.2 M $6.13 66
2018 Q1 25.9 M $189 M -$4.82 M $7.29 71
2017 Q4 25.8 M $211 M -$16.9 M $8.20 73
2017 Q3 27.1 M $284 M -$5.52 M $10.50 77
2017 Q2 26.1 M $288 M +$21.6 M $11.03 72
2017 Q1 26.6 M $257 M +$216 M $9.68 67
2016 Q4 4.3 M $44.7 M +$44.7 M $10.39 6